ACADIA PHARMACEUTICALS INC

About

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address central nervous system disorders. The company is best known for its flagship product, NUPLAZID, which is approved for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. ACADIA continues to expand its pipeline through research and development programs targeting conditions such as schizophrenia and depression within the neurological and psychiatric space.